严重的癌症性心脏病的当代管理
Suria Mano Geran1, Sargunann Naidu Krishnasamy Naido2, Aye Thida Hline1
1Cardiology Department, Queen's Hospital, Barking, Havering, and Redbridge University Hospitals NHS Trust, Romford, United Kingdom.
JACC. Case reports
|March 28, 2025
概括
癌症性心脏病 (CHD) 是癌症性综合征 (CS) 的严重并发症. 早期检测和多学科管理对于改善心血管疾病神经内分泌瘤患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 癌症性心脏病 (CHD) 是癌症性综合征 (CS) 的罕见但严重的并发症.
- 大约50%的CS患者会患上心脏病,主要影响右侧心脏门,导致右心力衰竭.
- 在晚期神经内分泌瘤 (NET) 患者中诊断和管理CHD存在重大挑战.
研究的目的:
- 突出在患有晚期癌症综合征 (CS) 的患者中诊断和管理癌症性心脏病 (CHD) 的挑战.
- 强调早期检测,及时管理和多学科护理的重要性,以改善神经内分泌瘤 (NET) 和心血管疾病患者的治疗结果.
主要方法:
- 一个71岁的男性病例摘要,患有转移性中肠神经内分泌瘤和CS,呈现出右心力衰竭恶化.
- 在癌症综合征 (CS) 的背景下,审查当前管理癌症性心脏病 (CHD) 的策略.
主要成果:
- 尽管得到了适当的治疗,但病情恶化并死亡,这凸显了管理晚期心血管疾病的困难.
- 早期发现和迅速管理CS至关重要,以防止进展到心脏病.
- 多学科护理和皮肤干预为高风险患者提供了有前途的选择.
结论:
- 建议在神经内分泌瘤 (NET) 患者中进行常规CHD查.
- 及时干预和专业的多学科管理对于改善癌性心脏病 (CHD) 的结果至关重要.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
545
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
545
Cardiomyopathy VI: Nursing Management
379
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
379
Cardiomyopathy V: Interprofessional Care
501
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
501
Heart Failure V: Medical Management
388
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
388
Angina IV: Management
330
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
330
Acute Coronary Syndrome IV: Interprofessional Care
315
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315


